Variable | Group A (≥ 70 y) (N = 23) | Group B (< 70 y) (N = 58) | p-value |
---|---|---|---|
Age (years) mean ± SD | 74.9 ± 3.4 | 50.9 ± 12.7 | 0.003* |
Gender (M/F) | 21/2 | 46/12 | 0.329 |
BMI (kg/m2) mean ± SD | 22.7 ± 3.1 | 22.3 ± 2.9 | 0.586 |
ASA score | |||
I/II | 16 | 53 | 0.137 |
III | 7 (30.4%) | 5(9.4%) | 0.047 |
ICGR 15(%) mean ± SD | 11.8 ± 4.5 | 10.3 ± 3.9 | 0.129 |
Album g/dl | 3.65 ± 0.5 | 3.84 ± 0.48 | 0.231 |
Total bilirubin mg/d | 0.83 ± 0.5 | 0.87 ± 0.46 | 0.625 |
Comorbidity (present/absent) | |||
Cardiac diseases n (%) | 4 (17.4) | 1 (1.7) | 0.041* |
Diabetes n (%) | 2 (8.7) | 4 (6.9) | 0.780 |
Hypertension n (%) | 7 (30.4) | 6 (10.3) | 0.551 |
COPD n (%) | 3 (13.0) | 1 (1.7) | 0.067 |
Cirrhosis n (%) | 4 (17.4) | 12 (20.6) | 0.078 |
Child-Pugh classification A/B/C | 91.3/ 8.7/0 | 82.8/ 17.2/0 | 0.493 |
HBV n (%) | 12 (52.2) | 37 (63.8) | 0.450 |
Tumor size (cm) | 4.7 ± 2.0 | 3.7 ± 2.1 | 0.403 |
Tumor size ≥5 cm n (%) | 7 (30.4) | 14 (24.1) | 0.582 |
Tumor number 1/2/≥3 (%) | 95.7/ 4.3/ 0 | 87.9/ 8.6/ 3.4 | 0.520 |
UICC7 | 0.882 | ||
Stage I | 12 (52.17%) | 37(63.79%) | |
Stage II | 5 (21.73%) | 6(10.34%) | |
Stage IIIA | 5(21.73%) | 12(20.69%) | |
Stage IIIB | 1(4.34%) | 2(3.45%) | |
Stage IIIC | 0 | 1(1.72%) | |
Previous abdominal operation n (%) | 10 (43.5) | 16 (27.6) | 0.193 |
Extent of live resection | 0.388 | ||
Wedge n (%) | 4 (17.39) | 18 (31.03) | |
Segmentectomy n (%) | 15(65.21) | 28(50.90) | |
Hemihepatectomy n (%) | 4 (17.39) | 12(20.68) |